Also trades as: INXB (NASDAQ) · $vol 8M

$101.32

-9.25 (-8.37%)

After Hours: $105.84 (+4.52, +4.46%)

Weekly Expected Move ±23.9%

$57 $83 $109 $135 $160

NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 40 · $1.5B mcap · 10M float · 3.85% daily turnover · Short 61% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE

53.5 / 100

NoneWeakNarrowWide

Primary source: Switching Costs · ROIC: 1054.9%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. INBX shows a Weak competitive edge (53.5/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. ROIC of 1054.9% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$325

Low

$325

Avg Target

$325

High

Based on 1 analyst since May 14, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 3Hold: 2Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$325.00

Analysts1

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-05-15	Stifel Nicolaus	—	Initiated	$325	—	+200.6%	$108.12

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

May 22, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. INBX receives an overall rating of C. Strongest factors: ROE (5/5). Areas of concern: DCF (2/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).

Rating Change History

Date	From	To
2026-05-14	D+	C
2026-04-22	C-	D+
2026-03-19	C	C-
2026-02-18	C-	C
2026-02-12	C	C-
2026-02-09	C-	C
2026-02-04	C	C-
2026-02-02	C-	C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+

Profitability

—

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

0.32

Distress Zone

Piotroski F-Score

1/9

✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓

Beneish M-Score

—

Ohlson O-Score

0.15

Bankruptcy prob: 53.8%

High Risk

Credit Rating

Score: 26.8/100

Trend: Deteriorating

Earnings Quality

—

OCF/NI: 1.01x

Accruals: 1.1%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. INBX scores 0.32, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. INBX scores 1/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. INBX's implied 53.8% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. INBX receives an estimated rating of B (score: 26.8/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

-12.23x

PEG

0.11x

P/S

1152.70x

P/B

-75.68x

P/FCF

-7.94x

P/OCF

—

EV/EBITDA

-8.80x

EV/Revenue

792.75x

EV/EBIT

-8.63x

EV/FCF

-7.81x

Earnings Yield

-12.42%

FCF Yield

-12.59%

Shareholder Yield

0.00%

Graham Number

—

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. INBX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

1.000

NI / EBT

Interest Burden

1.090

EBT / EBIT

EBIT Margin

-91.874

EBIT / Rev

Asset Turnover

0.008

Rev / Assets

Equity Multiplier

2.311

Assets / Equity

ROE

-183.9%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. INBX's ROE of -183.9% is driven by Asset Turnover (0.008), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

—

Price/Value

—

Margin of Safety

—

Premium

—

Assessment

Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 494 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$101.32

Median 1Y

$175.70

5th Pctile

$44.11

95th Pctile

$697.22

Ann. Volatility

85.0%

Analyst Target

$325.00

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Mark P. Lappe Chief Executive Officer and Chairman of the Board of Directors	$695,250	$—	$2,892,473
David J. Matly, M.B.A.	$589,170	$—	$1,435,940
Kelly D. Deck, C.P.A. Chief Financial Officer	$493,485	$—	$923,696

CEO Pay Ratio

125760:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $2,892,473

Avg Employee Cost (SGA/emp): $23

Employees: 1,000,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

1,000,000

0.0% YoY

Revenue / Employee

Rev: $1,300,000

Profit / Employee

$-140

NI: $-140,055,000

SGA / Employee

$23

Avg labor cost proxy

R&D / Employee

$113

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
ROE	42.7%	41.7%	13.2%	12.9%	-1.8%	-1.8%	-2.0%	-1.8%	-1.84%
ROA	6.0%	5.9%	9.8%	9.5%	-67.0%	-63.5%	-85.6%	-79.6%	-79.56%
ROIC	6.6%	8.6%	23.5%	27.4%	12.0%	11.1%	11.6%	10.5%	10.55%
ROCE	7.4%	7.2%	12.7%	12.4%	-1.1%	-1.0%	-1.1%	-1.1%	-1.06%
Gross Margin	1.0%	—	-5.9%	—	49.1%	—	—	—	—
Operating Margin	-1609.0%	—	-499.3%	—	-21.1%	—	—	—	—
Net Margin	18580.1%	—	-478.6%	—	-22.0%	—	—	—	—
EBITDA Margin	18638.5%	—	-471.8%	—	-19.1%	—	—	—	—
FCF Margin	-585.7%	-891.0%	-664.2%	-843.8%	-100.1%	-102.5%	-99.9%	-101.5%	-101.49%
OCF Margin	-573.6%	-876.4%	-656.8%	-836.3%	-99.9%	-102.4%	-99.8%	-101.5%	-101.48%
ROIC Economic	snapshot only								-84.55%
Cash ROA	snapshot only								-90.06%
NOPAT Margin	snapshot only								-74.78%
Pretax Margin	snapshot only								-100.14%
R&D / Revenue	snapshot only								77.13%
SGA / Revenue	snapshot only								17.67%
SBC / Revenue	snapshot only								6.68%

Valuation

Metric	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
P/E Ratio	0.11	0.13	0.13	0.13	-1.35	-3.36	-8.74	-8.05	-12.228
P/S Ratio	2098.15	2422.29	1114.64	1081.99	157.66	372.36	941.13	805.98	1152.704
P/B Ratio	4.82	5.57	1.67	1.62	1.65	3.90	153.07	131.09	-75.676
P/FCF	-3.58	-2.72	-1.68	-1.28	-1.58	-3.63	-9.42	-7.94	-7.942
P/OCF	—	—	—	—	—	—	—	—	—
EV/EBITDA	0.08	0.10	0.04	0.04	-0.49	-2.63	-9.52	-8.80	-8.801
EV/Revenue	1420.32	1744.46	391.90	359.25	54.41	269.11	927.90	792.75	792.747
EV/EBIT	0.08	0.10	0.04	0.04	-0.48	-2.58	-9.34	-8.63	-8.629
EV/FCF	-2.42	-1.96	-0.59	-0.43	-0.54	-2.63	-9.29	-7.81	-7.811
Earnings Yield	8.9%	7.5%	7.9%	8.0%	-74.2%	-29.7%	-11.4%	-12.4%	-12.42%
FCF Yield	-27.9%	-36.8%	-59.6%	-78.0%	-63.5%	-27.5%	-10.6%	-12.6%	-12.59%
PEG Ratio	snapshot only								0.110
Price/Tangible Book	snapshot only								131.087
Shareholder Yield	snapshot only								0.00%

Leverage & Solvency

Metric	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Current Ratio	5.25	5.25	3.94	3.94	3.94	3.94	3.93	3.93	3.930
Quick Ratio	5.25	5.25	3.94	3.94	3.94	3.94	3.93	3.93	3.930
Debt/Equity	4.83	4.83	0.06	0.06	0.06	0.06	13.39	13.39	13.388
Net Debt/Equity	-1.56	-1.56	-1.08	-1.08	-1.08	-1.08	-2.15	-2.15	-2.153
Debt/Assets	0.68	0.68	0.04	0.04	0.04	0.04	0.73	0.73	0.731
Debt/EBITDA	0.11	0.12	0.00	0.00	-0.05	-0.06	-0.84	-0.91	-0.914
Net Debt/EBITDA	-0.04	-0.04	-0.08	-0.08	0.93	1.01	0.14	0.15	0.147
Interest Coverage	347.58	339.40	330.47	215.03	-27.08	-16.21	-10.59	-9.18	-9.176
Equity Multiplier	7.08	7.08	1.35	1.35	1.35	1.35	18.33	18.33	18.326
Cash Ratio	snapshot only								3.675
Debt Service Coverage	snapshot only								-8.996
Cash to Debt	snapshot only								1.161
FCF to Debt	snapshot only								-1.233
Defensive Interval	snapshot only								372.2 days

Efficiency & Turnover

Metric	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Asset Turnover	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.008
Inventory Turnover	—	—	—	—	—	—	—	—	—
Receivables Turnover	0.13	0.13	0.50	0.50	2.38	2.38	4.53	4.53	4.530
Payables Turnover	0.00	0.07	0.16	0.23	0.28	0.26	0.33	0.31	0.309
DSO	2840	2840	725	725	153	153	81	81	80.6 days
DIO	—	0	0	0	0	0	0	0	0.0 days
DPO	—	5261	2329	1589	1323	1413	1116	1182	1182.1 days
Cash Conversion Cycle	—	-2421	-1604	-864	-1170	-1260	-1036	-1102	-1101.5 days
Fixed Asset Turnover	snapshot only								0.140
Cash Velocity	snapshot only								0.010
Capital Intensity	snapshot only								112.675

Growth (YoY)

Metric	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue	—	—	—	—	13.0%	13.0%	5.5%	5.5%	5.50%
Net Income	—	—	—	—	-1.1%	-1.1%	-1.1%	-1.1%	-1.08%
EPS	—	—	—	—	-1.1%	-1.1%	-1.1%	-1.1%	-1.07%
FCF	—	—	—	—	-1.4%	-61.0%	2.3%	21.8%	21.82%
EBITDA	—	—	—	—	-1.1%	-1.1%	-1.1%	-1.1%	-1.07%
Op. Income	—	—	—	—	-3.8%	25.8%	47.6%	59.1%	59.05%
OCF Growth	snapshot only								21.12%
Asset Growth	snapshot only								-18.97%
Equity Growth	snapshot only								-94.02%
Debt Growth	snapshot only								12.30%
Shares Change	snapshot only								0.76%

Growth Quality

Metric	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue Stability	—	—	—	—	—	—	—	—	—
Earnings Stability	—	—	—	—	—	—	—	—	—
Margin Stability	—	—	—	—	—	—	—	—	—
Rev. Growth Consistency	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	0.500
Earn. Growth Consistency	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.000
FCF Positive Streak	0	0	0	0	0	0	0	0	0
Earnings Persistence	—	—	—	—	—	—	—	—	—
Earnings Smoothness	—	—	—	—	—	—	—	—	—
ROE Trend	—	—	—	—	—	—	—	—	—
Gross Margin Trend	—	—	—	—	—	—	—	—	—
FCF Margin Trend	—	—	—	—	—	—	—	—	—
Sustainable Growth Rate	42.7%	41.7%	13.2%	12.9%	—	—	—	—	—
Internal Growth Rate	-1.2%	-1.2%	-1.1%	-1.1%	—	—	—	—	—

Cash Flow Quality

Metric	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
OCF/Net Income	-0.03	-0.05	-0.07	-0.10	0.85	0.92	0.93	1.01	1.013
FCF/OCF	1.02	1.02	1.01	1.01	1.00	1.00	1.00	1.00	1.000
FCF/Net Income	snapshot only								1.013
CapEx/Revenue	12.2%	14.6%	7.4%	7.5%	20.3%	3.4%	2.4%	0.8%	0.77%
CapEx/Depreciation	snapshot only								0.004
Accruals Ratio	6.22	6.18	10.50	10.46	-0.10	-0.05	-0.06	0.01	0.011
Sloan Accruals	snapshot only								-0.140
Cash Flow Adequacy	snapshot only								-13192.500

Dividends & Buybacks

Metric	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	—	—	—	—	—
FCF Payout Ratio	—	—	—	—	—	—	—	—	—
Total Payout Ratio	0.0%	0.0%	0.0%	0.0%	—	—	—	—	—
Div. Increase Streak	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Net Buyback Yield	-15.7%	-13.6%	-14.8%	-15.2%	0.0%	0.0%	-0.1%	-0.2%	-0.16%
Total Shareholder Return	-15.7%	-13.6%	-14.8%	-15.2%	0.0%	0.0%	-0.1%	-0.2%	-0.16%

DuPont Factors

Metric	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Tax Burden (NI/EBT)	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
Interest Burden (EBT/EBIT)	1.00	1.00	1.00	1.00	1.04	1.06	1.08	1.09	1.090
EBIT Margin	18633.74	18195.10	8858.23	8655.11	-112.76	-104.34	-99.33	-91.87	-91.874
Asset Turnover	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.008
Equity Multiplier	7.08	7.08	1.35	1.35	2.76	2.76	2.31	2.31	2.311

Per Share

Metric	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
EPS (Diluted TTM)	$125.48	$117.28	$122.02	$111.39	$-10.58	$-10.02	$-9.04	$-8.35	$-8.35
Book Value/Share	$2.94	$2.81	$9.23	$8.64	$8.64	$8.63	$0.52	$0.51	$-1.35
Tangible Book/Share	$2.94	$2.81	$9.23	$8.64	$8.64	$8.63	$0.52	$0.51	$0.51
Revenue/Share	$0.01	$0.01	$0.01	$0.01	$0.09	$0.09	$0.08	$0.08	$0.08
FCF/Share	$-3.96	$-5.76	$-9.18	$-10.91	$-9.06	$-9.27	$-8.38	$-8.47	$-8.47
OCF/Share	$-3.87	$-5.67	$-9.07	$-10.81	$-9.04	$-9.26	$-8.38	$-8.46	$-8.46
Cash/Share	$18.77	$17.97	$10.54	$9.87	$9.87	$9.86	$8.02	$7.97	$10.37
EBITDA/Share	$125.88	$117.71	$122.52	$112.08	$-10.03	$-9.27	$-8.18	$-7.51	$-7.51
Debt/Share	$14.19	$13.59	$0.56	$0.52	$0.52	$0.52	$6.91	$6.87	$6.87
Net Debt/Share	$-4.58	$-4.38	$-9.99	$-9.34	$-9.34	$-9.34	$-1.11	$-1.10	$-1.10

Academic Models

Metric	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	0.316
Altman Z-Prime	snapshot only								1.421
Piotroski F-Score	2	2	2	2	2	2	2	1	1
Beneish M-Score	—	—	—	—	8.30	—	—	—	—
Ohlson O-Score	snapshot only								0.152
ROIC (Greenblatt)	snapshot only								-1.10%
Net-Net WC	snapshot only								$-0.36

Credit

Metric	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Credit Rating	snapshot only								B
Credit Score	83.81	83.47	90.02	89.89	32.53	61.54	26.92	26.82	26.821
Credit Grade	snapshot only								15
Credit Trend	snapshot only								-63.067
Implied Spread (bps)	snapshot only								750.000
Industry Credit Rank	snapshot only								16
Sector Credit Rank	snapshot only								15

INBX NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet